ARDX Price / Book | ARDELYX, INC.

ARDELYX, INC. (ARDX) Price / Book

2026-09-03: Price/Book Ratio 6.21.
2026-06-30: Price/Book Ratio 8.53.
2026-03-31: Price/Book Ratio 9.95.
2025-12-31: Price/Book Ratio 8.53.

Historical market capitalization divided by filed shareholder equity.

Available history: 2014-06-30 to 2026-09-03
Data captured: 2026-09-04

Historical Price/Book Ratio

Date	Price/Book Ratio
2026-09-03	6.21
2026-06-30	8.53
2026-03-31	9.95
2025-12-31	8.53
2025-09-30	8.68
2025-06-30	6.76
2025-03-31	8.06
2024-12-31	6.96
2024-09-30	10.31
2024-06-30	11.87
2024-03-31	11.32
2023-12-31	8.64
2023-09-30	4.95
2023-06-30	6
2023-03-31	8.19
2022-12-31	5.76
2022-09-30	3.34
2022-06-30	1.71
2022-03-31	2.27
2021-12-31	1.73
2021-09-30	1.73
2021-06-30	6.64
2021-03-31	4.99
2020-12-31	4.8
2020-09-30	3.61
2020-06-30	4.21
2020-03-31	3.02
2019-12-31	3.57
2019-09-30	6.01
2019-06-30	2.46
2019-03-31	1.91
2018-12-31	0.97
2018-09-30	1.91
2018-06-30	1.41
2018-03-31	1.86
2017-12-31	2.25
2017-09-30	2.1
2017-06-30	1.67
2017-03-31	3.57
2016-12-31	3.48
2016-09-30	2.75
2016-06-30	2.15
2016-03-31	1.6
2015-12-31	4.32
2015-09-30	3.58
2015-06-30	2.91
2015-03-31	4.21
2014-12-31	5.79
2014-09-30	4.13
2014-06-30	4.66

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Avalo Therapeutics, Inc. (AVTX)	United States	$0.842B	-9.74
Immix Biopharma, Inc. (IMMX)	United States	$0.837B	-18.44
Cryoport, Inc. (CYRX)	United States	$0.881B	-21.29
Theravance Biopharma, Inc. (TBPH)		$0.885B	16.40
Obsidian Therapeutics, Inc. (OBX)	United States	$0.829B
LEXICON PHARMACEUTICALS, INC. (LXRX)	United States	$0.823B	-17.48
RIGEL PHARMACEUTICALS INC (RIGL)	United States	$0.893B	2.25
GYRE THERAPEUTICS, INC. (GYRE)	United States	$0.818B	-24.71
Apnimed, Inc. (APMD)	United States	$0.899B
GERON CORP (GERN)	United States	$0.803B	-12.14